Peter Chang
Dalhousie University(CA)Nationwide Children's Hospital(US)Beth Israel Deaconess Medical Center(US)University of Colorado Boulder(US)Hadassah Medical Center(IL)Saint John Regional Hospital(CA)NewPath Research(US)National University Heart Centre Singapore(SG)International Drug Development(FR)Massachusetts Institute of Technology(US)
Publications by Year
Research Areas
Prostate Cancer Diagnosis and Treatment, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Renal and related cancers
Most-Cited Works
- → A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis(2010)988 cited
- → Randomized, comparative study of interferon β-1a treatment regimens in MS(2002)633 cited
- → Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial(2008)481 cited
- → Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry(2015)393 cited
- → A Multicenter Prospective Study of 3,110 Consecutive Cases of Elective Epinephrine Use in the Fingers and Hand: The Dalhousie Project Clinical Phase(2005)388 cited
- → Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form